{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:41:33Z","timestamp":1784673693980,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ijgc-2021-002456","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T05:30:11Z","timestamp":1646631011000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation"],"prefix":"10.1016","volume":"32","author":[{"given":"Matthew W","family":"Parsons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9035-9399","authenticated-orcid":false,"given":"Y Jessica","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gita","family":"Suneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-002456_bb0010","author":"Uterine Cancer","year":"2021","journal-title":"Centers for disease control and prevention. Updated Jun 8 2021"},{"key":"10.1136\/ijgc-2021-002456_bb0015","author":"Society AC","year":"2021","journal-title":"Key statistics for endometrial cancer. Updated 12 Jan 2021"},{"key":"10.1136\/ijgc-2021-002456_bb0020","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2021-002456_bb0025","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ygyno.2004.11.033","article-title":"Lymphvascular space involvement: an independent prognostic factor in endometrial cancer","volume":"96","author":"Bri\u00ebt","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002456_bb0030","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/gyno.2002.6825","article-title":"Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer?","volume":"87","author":"Cohn","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002456_bb0035","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1111\/IGC.0b013e3181f5c688","article-title":"A role for adjuvant radiation in clinically early carcinoma of the endometrium?","volume":"20","author":"Thomas","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002456_bb0040","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.ejca.2015.05.015","article-title":"Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials","volume":"51","author":"Bosse","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2021-002456_bb0045","first-page":"419","article-title":"Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients","volume":"56","author":"Aalders","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2021-002456_bb0050","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002456_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.295.4.389","article-title":"Frequency and effect of adjuvant radiation therapy among women with stage I endometrial adenocarcinoma","volume":"295","author":"Lee","year":"2006","journal-title":"JAMA"},{"key":"10.1136\/ijgc-2021-002456_bb0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijrobp.2014.02.018","article-title":"Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal\/epidural anesthesia: incidence and risk factors","volume":"89","author":"Kirchheiner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002456_bb0065","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002456_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0140-6736(08)61767-5","article-title":"Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis","volume":"373","author":"ASTEC\/EN.5 Study Group","year":"2009","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002456_bb0075","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-002456_bb0080","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","article-title":"Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial","volume":"27","author":"Nout","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2021-002456_bb0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","article-title":"American brachytherapy task group report: adjuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review","volume":"16","author":"Harkenrider","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002456_bb0090","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ijrobp.2004.12.079","article-title":"Intravaginal high-dose-rate brachytherapy for stage I endometrial cancer: a randomized study of two dose-per-fraction levels","volume":"62","author":"Sorbe","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002456_bb0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","article-title":"Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the American Brachytherapy Society","volume":"15","author":"Harkenrider","year":"2016","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002456_bb0100","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0360-3016(90)90094-Z","article-title":"Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I","volume":"18","author":"Sorbe","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002456_bb0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2012.07.111","article-title":"A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer","volume":"127","author":"Townamchai","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-002456_bb0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.ijrobp.2010.10.071","article-title":"Determination of prognostic factors for vaginal mucosal toxicity associated with intravaginal high-dose rate brachytherapy in patients with endometrial cancer","volume":"82","author":"Bahng","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002456_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.brachy.2015.03.001","article-title":"Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma","volume":"14","author":"Park","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002456_bb0120","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ijrobp.2006.09.004","article-title":"Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma","volume":"67","author":"Fayed","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2021-002456_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.brachy.2019.03.001","article-title":"Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer?","volume":"18","author":"Ager","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1136\/ijgc-2021-002456_bb0130","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1136\/ijgc-2020-001929","article-title":"PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer","volume":"30","author":"van den Heerik","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2021-002456_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cncr.20445","article-title":"Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II--carcinoma of the endometrium","volume":"101","author":"Delaney","year":"2004","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002456_bb0140","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.22997","article-title":"Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2021-002456_bb0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijrobp.2006.03.059","article-title":"Effect of distance to radiation treatment facility on use of radiation therapy after mastectomy in elderly women","volume":"66","author":"Punglia","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24006005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-002456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:28:32Z","timestamp":1753234112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24006005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1048891X24006005"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-002456","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-002456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}